Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization

Je Sang Ko, Young Han Lee, Seung Yong Hwang, Youn Soo Lee, Seung Min Shin, Jae Hoon Hwang, Jin Kim, Yong Wook Kim, Sung Wuk Jang, Zae Young Ryoo, In Kyung Kim, Sung Eun Namkoong, Jin Woo Kim

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Basic studies of oncogenesis have demonstrated that either the elevated production of particular oncogene proteins or the occurrence of qualitative abnormalities in oncogenes can contribute to neoplastic cellular transformation. The purpose of this study was to identify unique oncogenes that are differentially expressed in human cancers and characterize their functions in tumorigenesis. To discover new putative oncogenes, the differential display RT-PCR method was applied using normal cervical tissues, cervical cancer cell lines, cervical cancer tissues, and metastatic tissues. We identified a new human cervical cancer oncogene HCCR-2 that was overexpressed in various human tumors including leukemia, lymphoma, and carcinomas of the breast, kidney, ovary, stomach, colon, and uterine cervix. Ectopic expression of HCCR-2 resulted in direct tumorigenic conversions of NIH/3T3 and Rat1 fibroblasts. Nude mice injected with NIH/3T3 cells stably transfected with HCCR-2 formed tumors in 4 weeks. The resultant tumors display characteristics of an epithelial carcinoma. In HCCR-2 transfected NCI-H460 cells and RKO cells, stabilization of the p53 tumor suppressor occurred without genetic mutation and correlated with functional impairment, as indicated by the defective induction of p53-induced p21WAF1, MDM2, and bax. These results indicate that HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor.

Original languageEnglish
Pages (from-to)4679-4689
Number of pages11
JournalOncogene
Volume22
Issue number30
DOIs
Publication statusPublished - 2003 Jul 24
Externally publishedYes

Fingerprint

Oncogenes
Uterine Cervical Neoplasms
Neoplasms
Carcinogenesis
NIH 3T3 Cells
Oncogene Proteins
Nude Mice
Cervix Uteri
Ovary
Lymphoma
Stomach
Colon
Leukemia
Fibroblasts
Breast Neoplasms
Carcinoma
Kidney
Cell Line
Polymerase Chain Reaction
Mutation

Keywords

  • Cervical cancer
  • HCCR-2
  • Oncogene
  • p53

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. / Ko, Je Sang; Lee, Young Han; Hwang, Seung Yong; Lee, Youn Soo; Shin, Seung Min; Hwang, Jae Hoon; Kim, Jin; Kim, Yong Wook; Jang, Sung Wuk; Ryoo, Zae Young; Kim, In Kyung; Namkoong, Sung Eun; Kim, Jin Woo.

In: Oncogene, Vol. 22, No. 30, 24.07.2003, p. 4679-4689.

Research output: Contribution to journalArticle

Ko, JS, Lee, YH, Hwang, SY, Lee, YS, Shin, SM, Hwang, JH, Kim, J, Kim, YW, Jang, SW, Ryoo, ZY, Kim, IK, Namkoong, SE & Kim, JW 2003, 'Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization', Oncogene, vol. 22, no. 30, pp. 4679-4689. https://doi.org/10.1038/sj.onc.1206624
Ko, Je Sang ; Lee, Young Han ; Hwang, Seung Yong ; Lee, Youn Soo ; Shin, Seung Min ; Hwang, Jae Hoon ; Kim, Jin ; Kim, Yong Wook ; Jang, Sung Wuk ; Ryoo, Zae Young ; Kim, In Kyung ; Namkoong, Sung Eun ; Kim, Jin Woo. / Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. In: Oncogene. 2003 ; Vol. 22, No. 30. pp. 4679-4689.
@article{be5dfeaffb774fa680e9d1992472d4f1,
title = "Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization",
abstract = "Basic studies of oncogenesis have demonstrated that either the elevated production of particular oncogene proteins or the occurrence of qualitative abnormalities in oncogenes can contribute to neoplastic cellular transformation. The purpose of this study was to identify unique oncogenes that are differentially expressed in human cancers and characterize their functions in tumorigenesis. To discover new putative oncogenes, the differential display RT-PCR method was applied using normal cervical tissues, cervical cancer cell lines, cervical cancer tissues, and metastatic tissues. We identified a new human cervical cancer oncogene HCCR-2 that was overexpressed in various human tumors including leukemia, lymphoma, and carcinomas of the breast, kidney, ovary, stomach, colon, and uterine cervix. Ectopic expression of HCCR-2 resulted in direct tumorigenic conversions of NIH/3T3 and Rat1 fibroblasts. Nude mice injected with NIH/3T3 cells stably transfected with HCCR-2 formed tumors in 4 weeks. The resultant tumors display characteristics of an epithelial carcinoma. In HCCR-2 transfected NCI-H460 cells and RKO cells, stabilization of the p53 tumor suppressor occurred without genetic mutation and correlated with functional impairment, as indicated by the defective induction of p53-induced p21WAF1, MDM2, and bax. These results indicate that HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor.",
keywords = "Cervical cancer, HCCR-2, Oncogene, p53",
author = "Ko, {Je Sang} and Lee, {Young Han} and Hwang, {Seung Yong} and Lee, {Youn Soo} and Shin, {Seung Min} and Hwang, {Jae Hoon} and Jin Kim and Kim, {Yong Wook} and Jang, {Sung Wuk} and Ryoo, {Zae Young} and Kim, {In Kyung} and Namkoong, {Sung Eun} and Kim, {Jin Woo}",
year = "2003",
month = "7",
day = "24",
doi = "10.1038/sj.onc.1206624",
language = "English",
volume = "22",
pages = "4679--4689",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "30",

}

TY - JOUR

T1 - Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization

AU - Ko, Je Sang

AU - Lee, Young Han

AU - Hwang, Seung Yong

AU - Lee, Youn Soo

AU - Shin, Seung Min

AU - Hwang, Jae Hoon

AU - Kim, Jin

AU - Kim, Yong Wook

AU - Jang, Sung Wuk

AU - Ryoo, Zae Young

AU - Kim, In Kyung

AU - Namkoong, Sung Eun

AU - Kim, Jin Woo

PY - 2003/7/24

Y1 - 2003/7/24

N2 - Basic studies of oncogenesis have demonstrated that either the elevated production of particular oncogene proteins or the occurrence of qualitative abnormalities in oncogenes can contribute to neoplastic cellular transformation. The purpose of this study was to identify unique oncogenes that are differentially expressed in human cancers and characterize their functions in tumorigenesis. To discover new putative oncogenes, the differential display RT-PCR method was applied using normal cervical tissues, cervical cancer cell lines, cervical cancer tissues, and metastatic tissues. We identified a new human cervical cancer oncogene HCCR-2 that was overexpressed in various human tumors including leukemia, lymphoma, and carcinomas of the breast, kidney, ovary, stomach, colon, and uterine cervix. Ectopic expression of HCCR-2 resulted in direct tumorigenic conversions of NIH/3T3 and Rat1 fibroblasts. Nude mice injected with NIH/3T3 cells stably transfected with HCCR-2 formed tumors in 4 weeks. The resultant tumors display characteristics of an epithelial carcinoma. In HCCR-2 transfected NCI-H460 cells and RKO cells, stabilization of the p53 tumor suppressor occurred without genetic mutation and correlated with functional impairment, as indicated by the defective induction of p53-induced p21WAF1, MDM2, and bax. These results indicate that HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor.

AB - Basic studies of oncogenesis have demonstrated that either the elevated production of particular oncogene proteins or the occurrence of qualitative abnormalities in oncogenes can contribute to neoplastic cellular transformation. The purpose of this study was to identify unique oncogenes that are differentially expressed in human cancers and characterize their functions in tumorigenesis. To discover new putative oncogenes, the differential display RT-PCR method was applied using normal cervical tissues, cervical cancer cell lines, cervical cancer tissues, and metastatic tissues. We identified a new human cervical cancer oncogene HCCR-2 that was overexpressed in various human tumors including leukemia, lymphoma, and carcinomas of the breast, kidney, ovary, stomach, colon, and uterine cervix. Ectopic expression of HCCR-2 resulted in direct tumorigenic conversions of NIH/3T3 and Rat1 fibroblasts. Nude mice injected with NIH/3T3 cells stably transfected with HCCR-2 formed tumors in 4 weeks. The resultant tumors display characteristics of an epithelial carcinoma. In HCCR-2 transfected NCI-H460 cells and RKO cells, stabilization of the p53 tumor suppressor occurred without genetic mutation and correlated with functional impairment, as indicated by the defective induction of p53-induced p21WAF1, MDM2, and bax. These results indicate that HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor.

KW - Cervical cancer

KW - HCCR-2

KW - Oncogene

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0042090260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042090260&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206624

DO - 10.1038/sj.onc.1206624

M3 - Article

C2 - 12879013

AN - SCOPUS:0042090260

VL - 22

SP - 4679

EP - 4689

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 30

ER -